ISSN: 1759-4790

Subscribe to this Journal

Journal Home

Journal Guideline

Nature Reviews Rheumatology Q1 Unclaimed

Nature Publishing Group United Kingdom

Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Nature Reviews Rheumatology is a journal indexed in SJR in Rheumatology with an H index of 182. It has an SJR impact factor of 4,818 and it has a best quartile of Q1. It has an SJR impact factor of 4,818.

Nature Reviews Rheumatology focuses its scope in these topics and keywords: developed, linked, ra, effectiveness, effective, distinct, disease, disappointmentsclassification, diabetes, decreased, ...

Type: Journal

Type of Copyright:

Languages:

Open Access Policy:

Type of publications:

Publication frecuency: -

Categories: Rheumatology (Q1)

Price

- €

Inmediate OA

NPD

Embargoed OA

- €

Non OA

Metrics

4,818

SJR Impact factor

182

H Index

174

Total Docs (Last Year)

527

Total Docs (3 years)

8003

Total Refs

4909

Total Cites (3 years)

290

Citable Docs (3 years)

8.63

Cites/Doc (2 years)

45.99

Ref/Doc

Comments

No comments ... Be the first to comment!

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID *

* The email or ORCID field is only to validate the authenticity of the comment, the identity will not be public. .

Other journals with similar parameters

Annals of the Rheumatic Diseases Q1
Lancet Rheumatology, The Q1
Arthritis and Rheumatology Q1
Osteoarthritis and Cartilage Q1
RMD Open Q1

Compare this journals

Aims and Scope

Best articles by citations

Fire and ice: syndecan-3 in inflammation

Optical molecular imaging to detect early endothelial activation: a promising novel modality for RA?

Genetic architectures of seropositive and seronegative rheumatic diseases

Evidence of gut-driven inflammation in new JIA

Could early biologics prevent disease?

Chondrocyte protection - SIRTified?

Optimizing withdrawal of therapy to sustain remission

Could IL-23 go solo as a therapeutic target for psoriasis?

Management of hereditary recurrent fevers - SHARE experience

IL-20 blockade to block bone loss?

Safety of biologic therapy in rheumatoid arthritis

A mechanism of B cell hyperactivity in SLE

SHOW MORE ARTICLES

Another cog in the mechanism of methotrexate

Tipping the balance towards resolution

How macrophages mediate inflammatory pain via ATP signaling

Anti-inflammatory hope for AIN457

Coeliac disease and rheumatoid arthritis: similar mechanisms, different antigens

Do autoantibodies to C3 exacerbate autoimmunity in SLE?

Dermal white adipose tissue implicated in SSc pathogenesis

siRNA-based therapeutic approaches for rheumatic diseases

Species-specific TLR signalling - insight into human disease

Progress in imaging in rheumatology

A nose for cartilage repair

Management of psoriatic arthritis from the view of the dermatologist